Medicus Pharma (NASDAQ:MDCX) announced that CEO Dr. Raza Bokhari will speak at the BTIG Virtual Biotech Conference 2025 on July 30 at 9:20 a.m. ET.
The fireside chat will be livestreamed for registered investors, with a recording available afterward.
Medicus’ lead asset, SkinJect Inc., is developing a patented dissolvable microneedle array to deliver doxorubicin directly to non-melanoma skin cancer lesions, particularly basal cell carcinoma.